Henney meeting with industry
This article was originally published in The Gray Sheet
Executive SummaryTwenty-member FDA/Industry Grass Roots Initiative Task Force meets with FDA Commissioner Jane Henney Dec. 18 in Boulder, Colorado "to discuss how the agency and industry can better work together to carry out changes specified in the FDA Modernization Act," Minnesota-based trade association Medical Alley reports. The meeting includes a two-hour public session with Henney and a two-hour session with the task force, which includes representatives from HIMA, Medical Alley and other regional associations for device manufacturers
You may also be interested in...
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.
With the pre-GDUFA backlog largely acted upon, the FDA expects ANDA approvals to decrease, but supplement actions to increase in FY 2020 and FY 2021.
February and March inspections deferred unless any are deemed mission critical. China director remains behind as staff evacuate.